RBC Capital’s Brian Abrahams just told Vertex shareholders to hold their horses—literally. Despite Vertex stock closing at ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.45% to $448.40 Wednesday, on what proved to be an all-around rough trading ...

VERTEX SECURITIES LTD - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Large Cap Equity Strategy” ...

RBC Capital slightly trimmed Vertex Pharmaceuticals’ price target from $423 to $420, but the firm’s rating stayed the course.